The microbiome market is one of the hottest areas for innovation in the life sciences space.  We are seeing an uptick in both research and venture capital dollars going into the microbiome industry—both in humans and plants.  As a result, the global microbiome market is expected to grow from $235.8 million in 2018 to $521.23 million by 2022.

Please join us for a panel discussion led by some of Boston’s most innovative companies in the space to learn about the science behind the microbiome, the utilization of emerging technologies, and various perspectives on the future of the industry.

Confirmed Speakers

Ryan Barrett, VP, Corporate Development & IP,  Axial Biotherapeutics

Dr. Martha Herbert , Assistant Professor of Neurology, Harvard Medical School, Pediatric Neurologist and Neuroscientist,  Massachusetts General Hospital

John "Brent" Hunt, Founder & CEO,  Soft Cell Biological Research

Brian Klein, Senior Staff Scientist, Vedanta Biosciences

Geoff van Maltzahn, Co-founder and Chief Innovation Officer,  Indigo